Lannett Company, Inc. has received approval from the US Food and Drug Administration (FDA) to manufacture Numbrino, the company’s branded topical anesthetic product, at its main plant in Seymour, IN. The company previously manufactured Numbrino and other liquid drug products at its Carmel, NY, plant, which it sold in March of this year as part of a restructuring and cost reduction plan.
